A popular, though controversial, view posits that Aß is upstream of tau in AD pathogenesis and triggers the conversion of tau from a normal to a toxic state (Bloom, 2014), implying that Aß is central in the pathology (Herrup, 2015; Musiek and Holtzman, 2015). The gene discussed is MAPT; the disease is Alzheimer disease.